\-\ Texto\\:\\ \ \(0\)\
\-\ 77\\ y\\/o\\ with\\ abdominal\\ pain\ \(1\)\
\-\ patient\\ may\\ have\\ biopsy\\ to\\ confirm\\ and\\ then\\ may\\ have\\ to\\ reduce\\ amiodorone\\ or\\ change\\ drug\\ regimen\\.\ \(0\)\
\-\ hyperdense\\ liver\ \(1\)\
\-\ increased\\ liver\\ attenuation\\ \\(amiodarone\\)\ \(0\)\
\-\ iron\\ deposition\\ \\(primary\\ or\\ secondary\\ hemochromatosis\\)\ \(0\)\
\-\ cisplatin\\ therapy\ \(0\)\
\-\ colloidal\\ gold\\ therapy\ \(0\)\
\-\ wilson\\ disease\ \(1\)\
\-\ thorotrast\ \(0\)\
\-\ amiodorone\\ therapy\ \(0\)\
\-\ 77\\ y\\.o\\.\\ woman\\ with\\ with\\ abdominal\\ pain\\ and\\ an\\ incidental\\ finding\\ on\\ chest\\ ct\\.\\ \\ has\\ history\\ of\\ amiodarone\\ treatment\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ amiodorone\\:\\ 0\\.4339366736128537\ \(0\)\
\-\ amiodarone\\:\\ 0\\.3528458406707704\ \(0\)\
\-\ 77\\:\\ 0\\.27136350235991863\ \(0\)\
\-\ therapy\\:\\ 0\\.23385630615379396\ \(0\)\
\-\ colloidal\\:\\ 0\\.20732482891950196\ \(0\)\
\-\ thorotrast\\:\\ 0\\.20048265118549188\ \(0\)\
\-\ liver\\:\\ 0\\.18718500531491075\ \(0\)\
\-\ cisplatin\\:\\ 0\\.18399696556455697\ \(0\)\
\-\ hemochromatosis\\:\\ 0\\.16220407457876243\ \(0\)\
\-\ wilson\\:\\ 0\\.15888000213298434\ \(0\)\
\-\ gold\\:\\ 0\\.1542014805140659\ \(0\)\
\-\ regimen\\:\\ 0\\.15029372682752534\ \(0\)\
\-\ iron\\:\\ 0\\.14958370941832022\ \(0\)\
\-\ abdominal\\:\\ 0\\.14840473409047647\ \(0\)\
\-\ reduce\\:\\ 0\\.13814434372865572\ \(0\)\
\-\ deposition\\:\\ 0\\.13688118936827698\ \(0\)\
\-\ may\\:\\ 0\\.13654839925843829\ \(0\)\
\-\ have\\:\\ 0\\.1355507574062214\ \(0\)\
\-\ confirm\\:\\ 0\\.12696586347258035\ \(0\)\
\-\ hyperdense\\:\\ 0\\.1248964008148272\ \(0\)\
\-\ drug\\:\\ 0\\.12345451591046035\ \(0\)\
\-\ attenuation\\:\\ 0\\.10380752198207888\ \(0\)\
\-\ change\\:\\ 0\\.1028080548880625\ \(0\)\
\-\ incidental\\:\\ 0\\.10056792341161144\ \(0\)\
\-\ pain\\:\\ 0\\.09709654363920849\ \(0\)\
\-\ then\\:\\ 0\\.0960393975121043\ \(0\)\
\-\ biopsy\\:\\ 0\\.09510091576433613\ \(0\)\
\-\ or\\:\\ 0\\.094395429620586\ \(0\)\
\-\ finding\\:\\ 0\\.08917881837145797\ \(0\)\
\-\ primary\\:\\ 0\\.08342336416423957\ \(0\)\
\-\ secondary\\:\\ 0\\.08041594624804531\ \(0\)\
\-\ with\\:\\ 0\\.07969855417753025\ \(0\)\
\-\ increased\\:\\ 0\\.0733647204356418\ \(0\)\
\-\ chest\\:\\ 0\\.07161431666850668\ \(0\)\
\-\ woman\\:\\ 0\\.07065818441734514\ \(0\)\
\-\ to\\:\\ 0\\.06783523967883018\ \(0\)\
\-\ treatment\\:\\ 0\\.06462755601574414\ \(0\)\
\-\ has\\:\\ 0\\.06197080878158176\ \(0\)\
\-\ disease\\:\\ 0\\.056950094971813164\ \(0\)\
\-\ and\\:\\ 0\\.0560697276545518\ \(0\)\
\-\ an\\:\\ 0\\.05188034353120769\ \(0\)\
\-\ history\\:\\ 0\\.05183438445045059\ \(0\)\
\-\ ct\\:\\ 0\\.05165143111068734\ \(0\)\
\-\ patient\\:\\ 0\\.044127142838765544\ \(0\)\
\-\ on\\:\\ 0\\.04097513546243103\ \(0\)\
\-\ of\\:\\ 0\\.02655032091542304\ \(0\)\
